CLO26-101: Comparison of Clinical and Pathological Tumour Staging Following CDK4/6 Inhibitor-Based Neoadjuvant Therapy in HR+/HER2- Breast Cancer.
- DOI
- 10.6004/jnccn.2025.7291
- Published
- 2026 Mar 31
- Container
- Journal of the National Comprehensive Cancer Network : JNCCN
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.6004/jnccn.2025.7291,
title = {CLO26-101: Comparison of Clinical and Pathological Tumour Staging Following CDK4/6 Inhibitor-Based Neoadjuvant Therapy in HR+/HER2- Breast Cancer.},
author = {Benn CA and Banda A and Waja F and van Loggerenberg D and Van Loggerenberg C},
year = {2026},
journal = {Journal of the National Comprehensive Cancer Network : JNCCN},
doi = {10.6004/jnccn.2025.7291},
url = {https://doi.org/10.6004/jnccn.2025.7291}
}RIS
TY - JOUR TI - CLO26-101: Comparison of Clinical and Pathological Tumour Staging Following CDK4/6 Inhibitor-Based Neoadjuvant Therapy in HR+/HER2- Breast Cancer. AU - Benn CA AU - Banda A AU - Waja F AU - van Loggerenberg D AU - Van Loggerenberg C PY - 2026 JO - Journal of the National Comprehensive Cancer Network : JNCCN DO - 10.6004/jnccn.2025.7291 UR - https://doi.org/10.6004/jnccn.2025.7291 ER -
APA
CA, B., A, B., F, W., D, V. L., & C, V. L. (2026). CLO26-101: Comparison of Clinical and Pathological Tumour Staging Following CDK4/6 Inhibitor-Based Neoadjuvant Therapy in HR+/HER2- Breast Cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. https://doi.org/10.6004/jnccn.2025.7291
Source records
- pubmed · retrieved 2026-09-25T10:25:00.628Z